Page 15 - ITPS-5-2

9 INNOSC Theranostics and Pharmacological Sciences, 2022, Vol. 5, No. 2 Dhokne et al.
[20] Jensen, T.S.; Hansson, P.T. Classification of Neuropathic Pain Model of Painful Peripheral Neuropathy. Neurosci. Lett., 2008,
Syndromes Based on Symptoms and Signs. Handb. Clin. Neurol., 436(2), 210–3.
2006, 81, 517–26. [41] Seltzer, Z.; Dubner, R.; Shir, Y. A Novel Behavioral Model of
[21] Zilliox, L. Neuropathic Pain. Continuum (Minneap Minn), 2017, Neuropathic Pain Disorders Produced in Rats by Partial Sciatic
23(2, Selected Topics in Outpatient Neurology), 512–32. Nerve Injury. Pain, 1990, 43(2), 205–18.
[22] Dworkin, R.H.; O’Connor, A.B.; Audette, J.; Baron, R.; [42] Malmberg, A.B.; Basbaum, A.I. Partial Sciatic Nerve Injury
Gourlay, G.K.; Haanpää, M.L.; Kent, J.L.; Krane, E.J.; LeBel, A.A.; in the Mouse as a Model of Neuropathic Pain: Behavioral and
Levy, R.M. Recommendations for the Pharmacological Neuroanatomical Correlates. Pain, 1998, 76(1-2), 215–22.
Management of Neuropathic Pain: An Overview and Literature [43] Vahidy, W.H.; Ong, W.Y.; Farooqui, A.A.; Yeo, J.F. Effects
Update. Mayo Clin. Proc., 2010, 85, S3–14. of Intracerebroventricular Injections of Free Fatty Acids,
[23] Kale, M.B.; Bajaj, K.; Umare, M.; Wankhede, N.L.; Lysophospholipids, or Platelet Activating Factor in a Mouse Model
Taksande, B.G.; Umekar, M.J.; Upaganlawar, A. Exercise and of Orofacial Pain. Brain Res., 2006, 174, 781–5.
Nutraceuticals: Eminent Approach for Diabetic Neuropathy. Curr. [44] Carlton, S.M.; Lekan, H.A.; Kim, S.H.; Chung, J.M. Behavioral
Mol. Pharmacol., 2022, 15(1), 108–28. Manifestations of an Experimental Model for Peripheral
[24] Baron, R.; Binder, A.; Wasner, G. Neuropathic Pain: Diagnosis, Neuropathy Produced by Spinal Nerve Ligation in the Primate.
Pathophysiological Mechanisms, and Treatment. Lancet Neurol., Pain, 1994, 56(2), 155–66.
2010, 9(8), 807–19. [45] Kim, S.H.; Chung, J.M. An Experimental Model for Peripheral
[25] Jaggi, A.S.; Jain, V.; Singh, N. Animal Models of Neuropathic Neuropathy Produced by Segmental Spinal Nerve Ligation in the
Pain. Fundam. Clin. Pharmacol., 2011, 25(1), 1–28. Rat. Pain, 1992, 50(3), 355–63.
[26] Dworkin, R.H.; O’Connor, A.B.; Backonja, M.; Farrar, J.T.; [46] Shields, S.D.; Eckert, W.A. 3 ; Basbaum, A.I. Spared Nerve
rd
Finnerup, N.B.; Jensen, T.S.; Kalso, E.A.; Loeser, J.D.; Injury Model of Neuropathic Pain in the Mouse: A Behavioral and
Miaskowski, C.; Nurmikko, T.J. Pharmacologic Management of Anatomic Analysis. J. Pain, 2003, 4(8), 465–70.
Neuropathic Pain: Evidence-based Recommendations. Pain, 2007, [47] Decosterd, I.; Woolf, C.J. Spared Nerve Injury: An Animal
132(3), 237–51. Model of Persistent Peripheral Neuropathic Pain. Pain, 2000,
[27] Sindrup, S.H.; Otto, M.; Finnerup, N.B.; Jensen, T.S. 87(2), 149–58.
Antidepressants in the Treatment of Neuropathic Pain. Basic Clin. [48] Yang, G.Y.; Lee, M.K.; Bae, Y.C.; Ahn, D.K. Intracisternal
Pharamacol. Toxicol., 2005, 96(6), 399–409. Administration of COX Inhibitors Attenuates Mechanical
[28] Gammaitoni, A.R.; Davis, M.W. Pharmacokinetics and Tolerability Allodynia Following Compression of the Trigeminal Ganglion in
of Lidocaine Patch 5% with Extended Dosing. Ann. Pharmacother., rats. Prog. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2009,
2002, 36(2), 236–40. 33(4), 589–95.
[29] Siddall, P.; Cousins, M.; Otte, A.; Griesing, T.; Chambers, R.; [49] Ahn, D.K.; Lim, E.J.; Kim, B.C.; Yang, G.Y.; Lee, M.K.; Ju, J.S.;
Murphy, T. Pregabalin in Central Neuropathic Pain Associated Han, S.R.; Bae, Y.C. Compression of the Trigeminal Ganglion
with Spinal Cord Injury: A Placebo-controlled Trial. Neurology, Produces Prolonged Nociceptive Behavior in Rats. Eur. J. Pain.,
2006, 67(10), 1792–800. 2009, 13(6), 568–75.
[30] O’Connor, A.B. Neuropathic Pain: Quality-of-life Impact, Costs [50] Courteix, C.; Eschalier, A.; Lavarenne, J. Streptozocin-induced
and Cost Effectiveness of Therapy. Pharmacoeconomics, 2009, 27, Diabetic Rats: Behavioural Evidence for a Model of Chronic Pain.
95–112. Pain, 1993, 53(1), 81–8.
[31] Cloninger, C.R. A Unified Biosocial Theory of Personality and its [51] Grover, V.S.; Sharma, A.; Singh, M. Role of Nitric Oxide in
Role in the Development of Anxiety States. Psychiatr. Dev., 1986, Diabetes-induced Attenuation of Antinociceptive Effect of
3(2), 167–226. Morphine in Mice. Eur. J. Pharmacol., 2000, 399(2-3), 161–4.
[32] Bennett, G.J. Pathophysiology and Animal Models of Cancer- [52] Genovese, T.; Esposito, E.; Mazzon, E.; Di Paola, R.; Muià, C.;
related Painful Peripheral Neuropathy. Oncologist, 2010, 15(S2), Meli, R.; Bramanti, P.; Cuzzocrea, S. Effect of Cyclopentanone
9–12. Prostaglandin 15-Deoxy-Δ12, 14PGJ2 on Early Functional
[33] Zeltser, R.; Beilin, B.Z.; Zaslansky, R.; Seltzer, Z. Comparison of Recovery from Experimental Spinal Cord Injury. Shock, 2008,
Autotomy Behavior Induced in Rats by Various Clinically-used 30(2), 142–52.
Neurectomy Methods. Pain, 2000, 89(1), 19–24. [53] Kumar, A.; Kaur, H.; Singh, A. Neuropathic Pain Models Caused
[34] Muthuraman, A.; Jaggi, A.S.; Singh, N.; Singh, D. Ameliorative by Damage to Central or Peripheral Nervous System. Pharmacol.
Effects of Amiloride and Pralidoxime in Chronic Constriction Rep., 2018, 70(2), 206–16.
Injury and Vincristine Induced Painful Neuropathy in Rats. Eur. J. [54] Taksande, B.G.; Faldu, D.S.; Dixit, M.P.; Sakaria, J.N.;
Pharmacol., 2008, 587(1-3), 104–11. Aglawe, M.M.; Umekar, M.J.; Kotagale, N.R. Agmatine Attenuates
[35] Devor, M.; Wall, P. Type of Sensory Nerve Fibre Sprouting to form Chronic Unpredictable Mild Stress Induced Behavioral Alteration
a Neuroma. Nature, 1976, 262(5570), 705–8. in Mice. Eur. J. Pharmacol., 2013, 720(1-3), 115–20.
[36] Riopelle, J.M. The Ethics of Using Animal Models to Study [55] Donertas, B.; Erol, K. Cannabinoids and Agmatine as Potential
Treatment of Phantom Pain. J. Am. Soc. Anesthesiologists, 1992, Therapeutic Alternatives for Cisplatin-induced Peripheral
76(6), 1069–9. Neuropathy. J. Exp Pharmcol., 2018, 10, 19–28.
[37] Bennett, G.J.; Xie, Y.K. A Peripheral Mononeuropathy in Rat that [56] Regunathan, S. Agmatine: Biological Role and Therapeutic
Produces Disorders of Pain Sensation Like those Seen in Man. Potentials in Morphine Analgesia and Dependence. AAPS J., 2006,
Pain, 1988, 33(1), 87–107. 8, E479–84.
[38] Wall, P.D.; Devor, M.; Inbal, R.; Scadding, J.W.; Schonfeld, D.; [57] Yeşilyurt, Ö.; Uzbay, I.T. Agmatine Potentiates the Analgesic
Seltzer, Z.; Tomkiewicz, M.M. Autotomy Following Peripheral Effect of Morphine by an α2-Adrenoceptor-mediated Mechanism
Nerve Lesions: Experimental Anesthesia Dolorosa. Pain, 1979, in Mice. Neuropsychopharmacology, 2001, 25(1), 98–103.
7(2), 103–13. [58] Taksande, B.G.; Sharma, O.; Aglawe, M.M.; Kale, M.B.;
[39] Li, S.X.; Cui, N.; Zhang, C.L.; Zhao, X.L.; Yu, S.F.; Xie, K.Q. Gawande, D.Y.; Umekar, M.J.; Kotagale, N.R. Acute Orexigenic
Effect of Subchronic Exposure to Acrylamide Induced on the Effect of Agmatine Involves Interaction Between Central α2-
Expression of bcl-2, Bax and Caspase-3 in the Rat Nervous Adrenergic and GABAergic Receptors. Biomed. Pharmacother.,
System. Toxicology, 2006, 217(1), 46–53. 2017, 93, 939–47.
[40] Sacerdote, P.; Franchi, S.; Trovato, A.E.; Valsecchi, A.E.; [59] Chimthanawala, N.; Patil, S.; Agrawal, R.; Kotagale, N.R.;
Panerai, A.E.; Colleoni, M. Transient Early Expression of Umekar, M.J.; Taksande, B.G. Inhibitory Influence of Agmatine in
TNF-α in Sciatic Nerve and Dorsal Root Ganglia in a Mouse Ethanol Withdrawal-induced Depression in Rats: Behavioral and

©2022 AccScience Publishing